Single cell TCR sequence study explores the limitations of TRBV9-depleting therapies in axial spondyloarthritis. Key fin
Tweet Content
Single cell TCR sequence study explores the limitations of TRBV9-depleting therapies in axial spondyloarthritis.
Key findings:
- Identified a clonally expanded TRBV5-5+ TCR in HLA-B27+ acute anterior uveitis.
- Alternative TRBVs may retain pathogenicity and evade anti-TRBV9… https://t.co/Aj8oslsTNX
Show on Archive Page
On
Display in Search Results
On
PDQ
Off